12 March 2026
Mujollari J et al. Blood 147 : 1229-1236, 2026
Mujollari J, Estruch Alrich M, Khadgawat P, Choudhary S, Gustavsson T, Dagil R, Redlinger N, Løppke C, Vidal Calvo E, Nordmaj MA, Theander TG, Heidenreich O, Nguyen Y, Qin S, Tølbøll Sørensen AL, Grønbæk K, Porse BT, Kircher B, Mueller J, Agerbæk M, Salanti A and Theilgaard-Mönch K. The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML. [PubMed]
